150 related articles for article (PubMed ID: 28759799)
1. Quantitative and qualitative analysis of regulatory T cells in B cell chronic lymphocytic leukemia.
Mpakou VE; Ioannidou HD; Konsta E; Vikentiou M; Spathis A; Kontsioti F; Kontos CK; Velentzas AD; Papageorgiou S; Vasilatou D; Gkontopoulos K; Glezou I; Stavroulaki G; Mpazani E; Kokkori S; Kyriakou E; Karakitsos P; Dimitriadis G; Pappa V
Leuk Res; 2017 Sep; 60():74-81. PubMed ID: 28759799
[TBL] [Abstract][Full Text] [Related]
2. Flow cytometric immunophenotyping of regulatory T cells in chronic lymphocytic leukemia: comparative assessment of various markers and use of novel antibody panel with CD127 as alternative to transcription factor FoxP3.
Dasgupta A; Mahapatra M; Saxena R
Leuk Lymphoma; 2013 Apr; 54(4):778-89. PubMed ID: 22989355
[TBL] [Abstract][Full Text] [Related]
3. Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
Ringelstein-Harlev S; Avivi I; Fanadka M; Horowitz NA; Katz T
Cancer Immunol Immunother; 2018 May; 67(5):739-748. PubMed ID: 29450641
[TBL] [Abstract][Full Text] [Related]
4. Regulatory T-cells in B-cell chronic lymphocytic leukemia: their role in disease progression and autoimmune cytopenias.
Lad DP; Varma S; Varma N; Sachdeva MU; Bose P; Malhotra P
Leuk Lymphoma; 2013 May; 54(5):1012-9. PubMed ID: 23009220
[TBL] [Abstract][Full Text] [Related]
5. Human regulatory T cells suppress proliferation of B lymphoma cells.
Grygorowicz MA; Biernacka M; Bujko M; Nowak E; Rymkiewicz G; Paszkiewicz-Kozik E; Borycka IS; Bystydzienski Z; Walewski J; Markowicz S
Leuk Lymphoma; 2016 Aug; 57(8):1903-20. PubMed ID: 26758248
[TBL] [Abstract][Full Text] [Related]
6. Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia.
Jak M; Mous R; Remmerswaal EB; Spijker R; Jaspers A; Yagüe A; Eldering E; Van Lier RA; Van Oers MH
Leuk Lymphoma; 2009 May; 50(5):788-801. PubMed ID: 19452318
[TBL] [Abstract][Full Text] [Related]
7. Circulating regulatory T cells in "clinical" monoclonal B-cell lymphocytosis.
D'Arena G; Rossi G; Minervini MM; Savino L; D'Auria F; Laurenti L; Del Principe MI; Deaglio S; Biagi A; De Martino L; De Feo V; Statuto T; Musto P; Del Poeta G
Int J Immunopathol Pharmacol; 2011; 24(4):915-23. PubMed ID: 22230398
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T-cell modulation by green tea in chronic lymphocytic leukemia.
D'Arena G; Simeon V; De Martino L; Statuto T; D'Auria F; Volpe S; Deaglio S; Maidecchi A; Mattoli L; Mercati V; Musto P; De Feo V
Int J Immunopathol Pharmacol; 2013; 26(1):117-25. PubMed ID: 23527714
[TBL] [Abstract][Full Text] [Related]
9. Targeting CD38 is lethal to Breg-like chronic lymphocytic leukemia cells and Tregs, but restores CD8+ T-cell responses.
Manna A; Kellett T; Aulakh S; Lewis-Tuffin LJ; Dutta N; Knutson K; Chini E; Pinilla-Ibarz J; Lamanna N; Manochakian R; Malavasi F; Sher T; Chanan-Khan AA; Ailawadhi S; Paulus A
Blood Adv; 2020 May; 4(10):2143-2157. PubMed ID: 32421811
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive Treg cells acquire the phenotype of effector-T cells in chronic lymphocytic leukemia patients.
De Matteis S; Molinari C; Abbati G; Rossi T; Napolitano R; Ghetti M; Di Rorà AGL; Musuraca G; Lucchesi A; Rigolin GM; Cuneo A; Calistri D; Fattori PP; Bonafè M; Martinelli G
J Transl Med; 2018 Jun; 16(1):172. PubMed ID: 29925389
[TBL] [Abstract][Full Text] [Related]
11. PI3Kδ inhibition modulates regulatory and effector T-cell differentiation and function in chronic lymphocytic leukemia.
Hanna BS; Roessner PM; Scheffold A; Jebaraj BMC; Demerdash Y; Öztürk S; Lichter P; Stilgenbauer S; Seiffert M
Leukemia; 2019 Jun; 33(6):1427-1438. PubMed ID: 30573773
[TBL] [Abstract][Full Text] [Related]
12. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia.
Giannopoulos K; Schmitt M; Kowal M; Wlasiuk P; Bojarska-Junak A; Chen J; Rolinski J; Dmoszynska A
Oncol Rep; 2008 Sep; 20(3):677-82. PubMed ID: 18695923
[TBL] [Abstract][Full Text] [Related]
13. Specific features of T- and NK-cellular immunity in chronic lymphocytic leukemia.
Pochtar EV; Lugovskaya SA; Naumova EV; Dmitrieva EA; Kostin AI; Dolgov VV
Klin Lab Diagn; 2021 Jun; 66(6):345-352. PubMed ID: 34105910
[TBL] [Abstract][Full Text] [Related]
14. Generation of B-cell chronic lymphocytic leukemia (B-CLL)-reactive T-cell lines and clones from HLA class I-matched donors using modified B-CLL cells as stimulators: implications for adoptive immunotherapy.
Hoogendoorn M; Wolbers JO; Smit WM; Schaafsma MR; Barge RM; Willemze R; Falkenburg JH
Leukemia; 2004 Jul; 18(7):1278-87. PubMed ID: 15116118
[TBL] [Abstract][Full Text] [Related]
15. Regulatory T cells in chronic lymphocytic leukemia: implication for immunotherapeutic interventions.
Jadidi-Niaragh F; Ghalamfarsa G; Yousefi M; Tabrizi MH; Shokri F
Tumour Biol; 2013 Aug; 34(4):2031-9. PubMed ID: 23681798
[TBL] [Abstract][Full Text] [Related]
16. A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemia.
D'Arena G; D'Auria F; Simeon V; Laurenti L; Deaglio S; Mansueto G; Del Principe MI; Statuto T; Pietrantuono G; Guariglia R; Innocenti I; Martorelli MC; Villani O; De Feo V; Del Poeta G; Musto P
Am J Hematol; 2012 Jun; 87(6):628-31. PubMed ID: 22460620
[TBL] [Abstract][Full Text] [Related]
17. Signaling molecules and cytokine production in T cells of patients with B-cell chronic lymphocytic leukemia (B-CLL): comparison of indolent and progressive disease.
Kiaii S; Choudhury A; Mozaffari F; Kimby E; Osterborg A; Mellstedt H
Med Oncol; 2005; 22(3):291-302. PubMed ID: 16110140
[TBL] [Abstract][Full Text] [Related]
18. Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro.
Lindqvist CA; Christiansson LH; Thörn I; Mangsbo S; Paul-Wetterberg G; Sundström C; Tötterman TH; Simonsson B; Enblad G; Frisk P; Olsson-Strömberg U; Loskog AS
Immunology; 2011 Jul; 133(3):296-306. PubMed ID: 21463298
[TBL] [Abstract][Full Text] [Related]
19. Increased CD39 expression on CD4(+) T lymphocytes has clinical and prognostic significance in chronic lymphocytic leukemia.
Perry C; Hazan-Halevy I; Kay S; Cipok M; Grisaru D; Deutsch V; Polliack A; Naparstek E; Herishanu Y
Ann Hematol; 2012 Aug; 91(8):1271-9. PubMed ID: 22349724
[TBL] [Abstract][Full Text] [Related]
20. Subjects with chronic lymphocytic leukaemia-like B-cell clones with stereotyped B-cell receptors frequently show MDS-associated phenotypes on myeloid cells.
Rodríguez-Caballero A; Henriques A; Criado I; Langerak AW; Matarraz S; López A; Balanzategui A; González M; Nieto WG; Cortesão E; Paiva A; Almeida J; Orfao A
Br J Haematol; 2015 Jan; 168(2):258-67. PubMed ID: 25252186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
